Pharmabiz
 

Aoxing Pharma receives GMP certification from SFDA in China

New YorkThursday, April 28, 2011, 16:00 Hrs  [IST]

Aoxing Pharmaceutical a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, has received GMP certification from the Chinese State Food and Drug Administration (SFDA) for the pre-treatment, extraction, tincture, and pill workshops, after a site inspection by SFDA. The milestone marks the completion of the Lerentang Pharmaceutical Company's manufacturing facility relocation from Shijiazhuang to Xinle City, Hebei Province.

Aoxing Pharma has received government support for the relocation from Shijiazhuang City and Hebei Province, totalling $269,231 (1,750,000 RMB) in the form of bank loan interest payment subsidies.

These facilities are expected to begin commercial production in mid-2011. This will enable Aoxing Pharma to supply all 11 of its licensed essential drugs to 29 provinces and municipalities in China (including military regions).

Zhenjiang Yue, chairman and CEO of Aoxing Pharma, commented, “Receiving the GMP certification is a very important achievement for Aoxing. This allows us to shift more management and financial resources to the development of our narcotics pipeline. We look forward to restarting the manufacturing and sale of these drugs in the next few months. As always, we are very appreciative of the local government's continuous support of Aoxing Pharma.”

Aoxing Pharmaceutical Company, Inc. is a US incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products.

 
[Close]